Idronoxil Suppository Combine With Radiotherapy for Metastatic Prostate Cancer
Status:
Terminated
Trial end date:
2019-09-17
Target enrollment:
Participant gender:
Summary
The aim of the study is to determine the toxicity of Idronoxil (NOX66) when used in
combination with palliative radiotherapy for metastatic prostate cancer